Bhatt Elizabeth — SEC insider filings
SEC reporting owner CIK 1748622. 20 insider filings on record with FilingPulse; latest filed 2026-10-19.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2021-01-14 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 7 filings — 59,000 shares, $2,293,477 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 25,000 shares @ $44.00 ($1,100,000) in Septerna, Inc., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Septerna, Inc. (SEPN) | President and COO | 7 | — | 9 legs · 41,000 sh · $1,598,822 | 14 |
| Applied Molecular Transport Inc. (AMTI) | Chief Bus. & Strategy Officer | 5 | — | 5 legs · 18,000 sh · $694,655 | 8 |
| eFFECTOR Therapeutics, Inc. (EFTR) | Director | 8 | — | — | 10 |
Insider filings — Bhatt Elizabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-19 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 1,094 @ $36.87 · Sale (S): 2,906 @ $37.61 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-08-13 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 18,681 @ $6.81 · Option exercise (M): 6,319 @ $2.76 · Sale (S): 25,000 @ $44 · Option exercise (M): 18,681 (derivative) @ $0 · Option exercise (M): 6,319 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 4,000 @ $33.99 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 2,573 @ $23.76 · Sale (S): 1,101 @ $25.24 · Sale (S): 326 @ $25.86 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 2,200 @ $28.46 · Sale (S): 1,800 @ $29.58 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2023-06-22 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-24 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-02-16 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 17,250 @ $0 · Grant/award (A): 80,500 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 31,500 @ $0 | EDGAR |
| 2021-10-08 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-08-27 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Conversion (C): 9,047 @ $0 · Disposition to issuer (D): 8,453 (derivative) @ $0 · Conversion (C): 9,047 (derivative) | EDGAR |
| 2021-07-22 | 4 | Applied Molecular Transport Inc. (AMTI) | Option exercise (M): 9,000 @ $4.61 · Sale (S): 6,640 @ $36.41 · Sale (S): 2,360 @ $37.43 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Applied Molecular Transport Inc. (AMTI) | Option exercise (M): 9,000 @ $4.61 · Sale (S): 971 @ $39.30 · Sale (S): 5,417 @ $40.38 · Sale (S): 2,612 @ $41.21 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 63,000 (derivative) @ $0 | EDGAR |
| 2021-01-14 | 4 | Locust Walk Acquisition Corp. (LWAC) | Other (J): 17,500 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748622 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs